Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXTO9V
|
||||
Drug Name |
[2-(2,3-difluoro-4-n-propylphenyl)phenoxy]acetaldehyde
|
||||
Synonyms |
CHEMBL390726
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C17H16F2O2
|
||||
Canonical SMILES |
CCCc1ccc(c(F)c1F)c2ccccc2OCC=O
|
||||
InChI |
InChI=1S/C17H16F2O2/c1-2-5-12-8-9-14(17(19)16(12)18)13-6-3-4-7-15(13)21-11-10-20/h3-4,6-10H,2,5,11H2,1H3
|
||||
InChIKey |
WMMHHGWEKUWSLN-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.